Return to homepagePandemic Pact

Evaluation of a new rapid COVID-19 diagnostic test

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-198

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Dr. Helen Lee, Prof. Ravindra Gupta

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Cancer Unit at the University of Cambridge

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

A University of Cambridge spinout company, Diagnostics for the Real World, has developed a rapid and accurate point-of-care system (SAMBA II) for the diagnosis of infection with SARS-CoV-2. The COVIDx clinical study is now underway to evaluate the SAMBA II machines, which are able to deliver a diagnosis in less than 90 minutes.